Richmond, Calif.-based Ekso Bionics Holdings Inc., a developer of exoskeleton solutions for medical and industrial applications, appointed Jack Glenn as its new CFO.

Glenn brings over 25 years of financial leadership experience within public and private companies in the life sciences industry, Ekso said in a statement. He replaces Max Scheder-Bieschin who served the company for eight years.

Glenn is the former CFO for Sonendo Inc., a privately held, venture-backed healthcare technology company.

Ekso Bionics' products range from technologies supporting mobility of patients with paralysis to solutions enhancing human capabilities for industrial use.